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Reconstitution of eukaryotic Okazaki fragment processing
implicates both one- and two-nuclease pathways for processing
flap intermediates. In most cases, FEN1 (flap endonuclease 1) is
able to efficiently cleave short flaps as they form. However, flaps
escaping cleavage bind replication protein A (RPA) inhibiting
FEN1.The flapsmust thenbe cleavedbyDna2nuclease/helicase
before FEN1 can act. Pif1 helicase aids creation of long flaps.
The pathways were considered connected only in that the prod-
ucts of Dna2 cleavage are substrates for FEN1. However, results
presented here show that Dna2, Pif1, and RPA, the unique pro-
teins of the two-nuclease pathway from Saccharomyces cerevi-
siae, all stimulate FEN1 acting in the one-nuclease pathway.
Stimulation is observed on RNA flaps representing the initial
displacement and on short DNA flaps, subsequently displaced.
Neither the RNA nor the short DNA flaps can bind the two-
nuclease pathway proteins. Instead, direct interactions between
FEN1 and the two-nuclease pathway proteins have been
detected. These results suggest that the proteins are either part
of a complex or interact successively with FEN1 because the
level of stimulation would be similar either way. Proteins bound
to FEN1 could be tethered to the flap base by the interaction of
FEN1 with PCNA, potentially improving their availability when
flaps become long. These findings also support amodel inwhich
cleavage by FEN1 alone is the preferred pathway, with the first
opportunity to complete cleavage, and is stimulated by compo-
nents of the backup pathway.
Double-stranded DNA in eukaryotes is synthesized through
elongation of leading and lagging strands copied using the orig-
inal DNA as a template. The leading strand DNA is made in a
continuous manner by DNA polymerase , which adds nucleo-
tides in the same direction of the opening replication fork (1).
The lagging strand, which grows in the opposite direction,must
be made discontinuously, through the creation of short (150-
nt) oligonucleotides known as Okazaki fragments (2). This
process begins with DNA polymerase /primase (pol ),2
which makes a mixed primer initiating with 10–12 nt of RNA,
to which 10–20 nt of DNA is added (3). The primer is then
lengthened by DNA polymerase  (pol ). After adding
deoxynucleotides to make the bulk of the fragment, pol 
encounters the adjacent downstreamOkazaki fragment. At this
point, pol  will displace the downstream fragment into a flap
while continuing to synthesize DNA, a process called strand
displacement synthesis (4, 5). These flaps are cleaved by specific
endonucleases, creating a nick that will then be sealed by DNA
ligase I. The ligation event finishes the production of the com-
plete DNA strand.
Two pathways have been suggested for flap processing. The
first pathway, proposed byBurgers and co-workers (6–8) based
on reconstitutions in vitro, is referred to as the FEN1-only path-
way, or “one-nuclease pathway.” As the name suggests, in this
pathway, the only nuclease involved in flap cleavage is FEN1
(flap endonuclease 1). FEN1 is an endonucleasewith a preferred
substrate having a 5-flap with a 1-nucleotide-long 3-flap.
After pol  displaces a short flap of only a fewnucleotides, FEN1
is able to bind to the 5-end of the flap and track to its base,
where it proceeds to cleave off the entire flap, leaving behind
only a nick (4, 9, 10).
Reconstitutions of Okazaki fragment processing in vitro sug-
gest that FEN1 cleaves most flaps when they are only a few
nucleotides long. However, in these reactions, a small fraction
of flaps escape FEN1 cleavage and achieve greater lengths (11,
12). Once this occurs, the flaps can be bound by replication
protein A (RPA), the eukaryotic single-stranded binding pro-
tein. RPA is able to stably bind flaps greater than 22 nt in length,
and doing so has been shown to inhibit FEN1 cleavage (13, 14).
Bae and Seo (15) proposed a second pathway through which
they suggested that flaps are cleaved in vivo. In the two-nuclease
pathway, cleavage by the endonuclease Dna2 is promoted on
RPA-coated flaps (14). Dna2 exhibits both a directional 5–3
endonuclease activity and a 5–3 helicase activity that is spe-
cific for forked substrates (15, 16). Like FEN1, Dna2 enters
flaps from the 5-end. However, whereas FEN1 cleaves a sin-
gle time, Dna2 cleaves multiple times while tracking on the
flap. Also, unlike FEN1, Dna2 is not able to cleave the flap
entirely but leaves a terminal flap of 5–7 nt in length (17).
RPA is no longer able to bind these short flaps, allowing
FEN1 to freely bind and cleave the remainder of the flap.
Although the two-nuclease pathway was originally proposed
to predominate, later reconstitutions suggest that its role is
to complete processing of the small fraction of flaps that are
missed by FEN1 (11, 12, 15).
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An additional protein, Pif1, has been implicated in lagging
strand synthesis. Pif1 is a 5–3 helicase that has been shown to
have an important role in telomere and mitochondrial DNA
maintenance (18). Interestingly, Pif1 has been shown to have a
genetic interaction with Dna2; deletion of PIF1 rescues the
lethality created by a Dna2 nuclease-deficient mutant in yeast
(19). Previous work from our research group has also suggested
that Pif1 plays a role in the two-nuclease pathway by aiding the
creation of longer flaps during Okazaki fragment processing
(12, 20).
Although originally formulated as two independent path-
ways, some evidence suggests that the one- and two-nuclease
pathways have relevant interactions. Previous characterization
of Dna2 suggests that it is able to stimulate FEN1 although
indirectly. By cleaving long flaps bound by RPA, Dna2 not only
removes the RPA block but also leaves short flaps that aremore
readily processed by FEN1 (21, 22).
We therefore questioned here whether the two pathways
truly operate independently (i.e. whether the protein compo-
nents of the two-nuclease pathway performed no function until
a flap grew to the length that would serve as a substrate for the
two-nuclease pathway). In such a model, relative processing of
substrates through either of the two pathways would depend
solely on the fraction of flaps missed for cleavage by FEN1.
Alternatively, the two pathwaysmight be interactive, with com-
ponents of one affecting the efficiency of the other. For exam-
ple, the components of the two-nuclease pathway might inter-
fere with FEN1 cleavage, helping to generatemore substrate for
their pathway. To test this concept, we measured the effect of
the unique two-nuclease protein components on the ability of
FEN1 to cleave substrates of the one-nuclease pathway. Sur-
prising results showed that the two-nuclease proteins all stim-
ulate FEN1 activity in a way that suppresses formation of the
substrate for their own pathway.
EXPERIMENTAL PROCEDURES
Materials—[-32P]dCTP and [-32P]ATP were obtained
fromPerkinElmer Life Sciences. Oligonucleotides were synthe-
sized by Integrated DNA Technologies (Coralville, IA). T4
polynucleotide kinase and Escherichia coli DNA polymerase I
Klenow were obtained from Roche Applied Science. Other
reagents were of the best grade commercially available.
Protein Expression and Purification—Saccharomyces cerevi-
siae Rad27 (FEN1) was cloned into the T7 expression vector
pET-24b (Novagen/EMD Biosciences, Madison, WI), ex-
pressed in E. coli BL21(DE3) codon plus strain (Stratagene),
and purified as described previously (23). S. cerevisiae Pif1 and
Pif1 K264A were cloned into the pET-28b bacterial expression
vector (Novagen/EMD Biosciences), expressed in the E. coli
Rosetta strain (Novagen/EMD Biosciences), and purified as
described previously (24). S. cerevisiae RPA was overexpressed
and purified from E. coli as previously described (25). S. cerevi-
siaeDna2 E675Awas produced by site-directedmutagenesis as
previously described. Wild-type Dna2 and Dna2 E675A were
overexpressed and purified from baculovirus High Five cells as
previously described (26).
Oligonucleotide Substrates—Oligonucleotides were used to
design substrates that simulate Okazaki fragment processing
intermediates. Downstream primers of 28, 32, and 56 nt in
length were annealed at their 3-ends to a 20-nt labeling tem-
plate with a 5-GCTA overhang and radiolabeled using
[-32P]dCTP and Klenow polymerase. For 5 labeling, the
downstream primer of 28 nt was labeled with [-32P]ATP using
polynucleotide kinase. Radiolabeled primers were separated by
electrophoresis on a 15%, 7 M urea polyacrylamide gel and then
gel-purified. Substrates were then created by annealing primer
components in annealing buffer (50 mM Tris-HCl, pH 8.0, 50
mM NaCl, 1 mM dithiothreitol), heating at 95 °C for 5 min,
transferring to 70 °C, and slowly cooling to room temperature.
The annealing ratio was 1:2:4 (downstream primer/template/
upstream primer). Each downstream primer contains a region
of 26 nt complementary to the template, resulting in 2-, 6-, and
30-nt unannealed 5-flaps, respectively. The template itself is 51
nt in length. The upstream primer is 26 nt in length, containing
a 25-nt region complementary to the template, leaving a 1-nt
3-flap. These substrates were designed to allow measurement
of cleavage by FEN1. Additionally, an RNA-DNA substrate was
created utilizing the above procedure. However, for the RNA-
DNA substrate, the 32-nt-long downstream primer contained
12 nt of RNA in the 5-region. Annealing resulted in a substrate
with a 6-nt 5 RNA flap and 6 nt of RNA annealed to the tem-
plate. Specific substrates used in each figure are indicated in the
legends and pictured at the top of the figures. The location of
the radiolabel on the downstream primer is indicated by an
asterisk in the respective figures.
Cleavage Assays—For the fixed flap cleavage reactions, one
or more of the proteins, FEN1, Pif1, Dna2, or RPA, were mixed
together in reaction buffer containing 30 mM HEPES, 40 mM
KCl, 4mMMgCl2, 0.01%Nonidet P-40, 0.5% inositol, 0.1mg/ml
bovine serum albumin, 1 mM dithiothreitol, 0.5 mM ATP, and
5% glycerol. To start the reactions, 5 fmol of 3-radiolabeled
substrate was added for a total volume of 20 l. Reactions were
run for 10min at 37 °C. Reactions were stopped by adding 20l
of 2 termination dye (90% formamide (v/v), 10 mM EDTA,
0.01% bromphenol blue, and xylene cyanol), followed by heat-
ing at 95 °C for 5min. Productswere separated by electrophore-
sis on a 22.5%, 7 M urea polyacrylamide gel for 1 h and 40min at
70 watts. The gel was placed on filter paper and vacuum-dried
on a gel drier (Bio-Rad). Dried gels were exposed to a phosphor
screen, which was scanned using a GE Healthcare Phosphor-
Imager and analyzed with ImageQuant version 5.0 software.
Electrophoretic Mobility Shift Assay (EMSA)—Binding effi-
ciency of Pif1, RPA, or Dna2 to a substrate with a flap of either
2, 6, or 30 nt was assessed using EMSA. For clearer visualiza-
tion, the 2-nt flap substrate was 5-labeled in this experiment.
Five fmol of substrate was incubated with increasing concen-
trations of the specific protein at either 50 or 500 fmol and
incubated for 10 min at 37 °C in the same reaction buffer as
described above but lacking ATP and MgCl2. The reactions
were loaded on prerun, non-denaturing 12% polyacrylamide
gels in 1TBE. Gels were subjected to electrophoresis for 1.5 h
at a constant 250 V.
Helicase Assay—To measure the helicase activity of Pif1 or
Dna2 or the strand melting activity of RPA, the respective pro-
teinwas added to a reaction containing a flap substrate of either
2, 6, or 30 nt in the reaction buffer utilized for our cleavage
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reactions. For clearer visualization, the 2-nt flap substrate was
5-labeled in this experiment. Five fmol of substrate was incu-
bated with concentrations of protein of 50 or 500 fmol and
incubated for 10 min at 37 °C. The reactions were terminated
using a helicase dye consisting of 30% glycerol, 50 mM EDTA,
0.9% SDS, 0.125% bromphenol, and 0.125% xylene cyanol. The
reactions were loaded on prerun, non-denaturing 12% poly-
acrylamide gels in 1 TBE. Gels were subjected to electro-
phoresis for 1.5 h at a constant 250 V.
Binding Assay—Purified S. cerevisiae FEN1 (1 ng) and 1 ng of
a purified two-nuclease protein (S. cerevisiae Dna2, Pif1, or
RPA) were allowed to bind together in a coupling buffer con-
sisting of 25mmHEPES (pH 7.5), 100mMNaCl, 1mM EDTA, 1
mM dithiothreitol, and 10% glycerol for 2 h at 4 °C (in a 1:1
ratio). When three proteins were bound to FEN1, 2 ng of the
competing proteinswere added first and allowed to bind for 2 h.
Then 1 ng of the antibody-specific protein was added and incu-
bated with themixture for an additional 2 h. Antibody to either
Dna2, prepared as previously described (27), Pif1 (sc-48377
(Santa Cruz Biotechnology, Inc. (Santa Cruz, CA)), or RPA70
(kindly provided by Dr. Marc Wold) or control IgG (sc-2027,
Santa Cruz Biotechnology, Inc.) were prebound to protein
A-agarose for 1 h at room temperature and washed twice with
phosphate-buffered saline. The bound proteins were then
added to the washed protein A-agarose-antibody complex and
incubated overnight at 4 °C with end-over mixing. The follow-
ing day, the proteins were released from the protein A-agarose
using elution buffer. The immunoprecipitates were separated
on precast 4–20% gels (Bio-Rad). Western blot analysis was
performed with anti-FEN1 polyclonal antibody (ab17993,
Abcam). Cross-reactivity of mouse monoclonal Pif1 antibody
with purified S. cerevisiae Pif1 was tested and confirmed before
the immunoprecipitation.
The amount of each protein used in each experiment is given
in the appropriate figure legend. All enzyme assays were
repeated at least in triplicate with a representative gel shown in
each figure.
RESULTS
Dna2 and RPA have been implicated in the two-nuclease
pathway, important for the proper cleavage of long flaps formed
during eukaryotic Okazaki fragment processing. Previous work
has also shown that Pif1 helicase promotes the long flap path-
way. Although the two-nuclease and FEN1-only pathways
are generally represented as occurring separately from one
another, we considered the possibility that the pathways have
evolved to be interactive. Specifically, we set out to examine
whether the components of the two-nuclease pathway influ-
ence the efficiency of the one-nuclease pathway.
Substrate Design—For our experiments, we created three
substrates with flap lengths of 2, 6, or 30 nt. The 2-nt flap rep-
resents an intermediate formed during the beginning of strand
displacement synthesis, which we would expect to have no
affinity for Dna2, RPA, or Pif1. The 6-nt flap represents an
intermediate considered at the borderline for detectable bind-
ing by the three two-nuclease pathway proteins. The 30-nt flap
serves as a positive control to which all three proteins should be
able to bind with maximum affinity. FEN1 is able to bind and
cleave all of these flaps. By utilizing these three different
lengths, we have been able to distinguish the influence of each
protein on flap cleavage by FEN1 and whether that influence
depends on binding of each protein to the flap.
Because our experimental protocol utilized fixed flap sub-
strates and because Dna2 and Pif1 are helicases, the potential
existed that the helicase functions of these proteins would dis-
rupt the substrates. The concern was that the helicases would
partially displace the downstream primer, creating a gap. This
would alter the double flap configuration favored by FEN1,
decreasing FEN1 cleavage activity andmasking any stimulatory
effects. This is not an issue in vivo because elongation of the
upstream primer by pol  would continuously renew the
favored double flap structure. To ensure that we did not expe-
rience interference, we chose a buffer system in which the heli-
case functions would cause minimal disruption of our
substrates.
Effect of Dna2 on FEN1 Cleavage—Dna2 was found to stim-
ulate FEN1 cleavage on long flaps. It has been proposed that the
ability of Dna2 to cleave long 5-flaps, terminating in a mini-
mum flap length of about 6 nt, promotes FEN1 to cleave the
remainder of the flap more efficiently. The action of Dna2
would remove regions of secondary structure in the flap that
might interfere with tracking of FEN1. Moreover, Dna2 would
also reduce the flap length so that RPA could not bind to inter-
fere with FEN1 tracking. However, we were interested in deter-
mining whether Dna2 is able to directly stimulate FEN1 on the
short flaps cleaved in the one-nuclease pathway.
To measure whether Dna2 influences FEN1 activity, we first
performed a cleavage assay. For this experiment, amounts of
Dna2 ranging from 0 to 50 fmol were added to reactions con-
taining FEN1 and varying flap length substrates.We observed a
dose-dependent stimulation of FEN1 cleavage by Dna2 (Fig.
1A). Interestingly, in addition to measuring stimulation on the
30-nt flap substrate, to which Dna2 is expected to bind avidly,
we also measured significant stimulation on the 6- and 2-nt
flaps, implying that the ability of Dna2 to stimulate FEN1 is
independent of Dna2 binding to the substrate. After adding 50
fmol of Dna2 to the reaction in the presence of ATP, we mea-
sured a stimulation of FEN1 cleavage of 12.5-fold on the 2-nt
flap substrate, 44.2-fold on the 6-nt flap substrate, and 15.9-fold
on the 30-nt flap substrate.
Additionally, this experiment was performed in the absence
of ATP. This was done to determine whether the helicase func-
tion of Dna2 is responsible for its ability to stimulate FEN1. The
outcome was similar, showing that Dna2 is able to stimulate
FEN1 cleavage even in the absence of helicase function.
To confirm the expected binding characteristics of Dna2 to
the different length flap substrates, we performed an electro-
phoretic mobility shift assay (EMSA) utilizing all three sub-
strates (Fig. 1B). For these EMSA measurements, we used pro-
tein levels of 50 and 500 fmol. Whereas 50 fmol of Dna2
represents the highest amount used in our cleavage assays, to
observe high efficiency binding of the protein for an EMSA, a
10-fold increase in protein (i.e. 500 fmol) was needed. In the
EMSA reactions, we utilized a buffer lacking both ATP and
Mg2 to prevent unwinding or, in the case ofDna2, cleavage. At
50 fmol of Dna2, we detected no binding to the 2- and 6-nt flap
Stimulation of Eukaryotic Okazaki Fragment Processing
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substrates, and a small amount of Dna2 bound to the 30-nt flap
substrate. At 500 fmol, there was little binding to the 2-nt
flap substrate. More binding was observed on the 6-nt flap sub-
strate, with the most binding occurring on the 30-nt flap sub-
strate in the presence of 500 fmol of Dna2. This is consistent
with the binding properties expected from Dna2.
Finally, we performed a helicase assay utilizing the nuclease-
deficient mutant of Dna2. Although the absence of ATP
negated the helicase activity of Dna2 in the cleavage assay, the
helicase assay was performed in conditions that allowed for
maximal helicase activity by the nuclease-deficient Dna2
mutant. Although Dna2 did not show stable binding to the
short flap substrates in our EMSA study, we envisioned that
there could be transient binding of Dna2 to these substrates,
allowing for some helicase activity. However, at 50 fmol of
Dna2, themaximum amount used in our cleavage assay, we saw
only minimal unwinding and only on the 30-nt flap (Fig. 2).
Even at 500 fmol ofDna2, unwinding of the downstreamprimer
could only be observed on the 30-nt flap, suggesting that robust
helicase activity by Dna2 requires a longer single-stranded
DNA region for it to track and unwind the substrate. This con-
firms that althoughDna2 can stimulate FEN1 cleavage on short
flaps, it cannot perform its helicase or endonuclease functions.
Effect of Pif1 on FEN1 Cleavage—Pif1 has previously been
shown to promote utilization of the two-nuclease pathway in
reconstitution reactions. Because it appears to be a two-nucle-
ase pathway component, we assessed the ability of Pif1 to stim-
ulate FEN1 on short flaps.
As with Dna2, we first performed a cleavage assay, now uti-
lizing FEN1 and Pif1. Varying amounts of Pif1, ranging from 0
to 50 fmol, were added to reactions containing FEN1. Results
revealed a dose-dependent stimulation of FEN1 cleavage by
FIGURE 1. Dna2 stimulates FEN1 cleavage of 2-, 6-, and 30-nt flap sub-
strates. A, cleavage by FEN1 (2 fmol) was assayed on a 2-, 6-, and 30-nt flap
substrate in the presence or absence of ATP and varying amounts of Dna2 (5,
15, 25, or 50 fmol) as indicated in the figure and described under “Experimen-
tal Procedures.” The substrate is depicted at the top with the location of the
radiolabel indicated by an asterisk. The length of the flap utilized is denoted
above the corresponding lanes. The presence () and absence () of compo-
nents are indicated. B, Dna2 binding activity (50 or 500 fmol) was measured
on a 2-, 6-, and 30-nt flap substrate by non-denaturing PAGE.
FIGURE 2. Substrate unwinding by Pif1, Dna2, andRPA.Unwinding of a 2-,
6-, and 30-nt substrate by Pif1, Dna2 E675A, or RPA was assessed by non-
denaturing PAGE using 50 or 500 fmol of protein, as indicated in the figure
and described under “Experimental Procedures.” Substrate depictions and
designations are as in Fig. 1.
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Pif1 (Fig. 3A). As with Dna2, stimulation of FEN1 occurred not
only for cleavage of the 30-nt flap substrate but also with the 6-
and 2-nt flap substrates. This implies that the ability of Pif1 to
stimulate FEN1 is not dependent on Pif1 binding to the flap.
The addition of 50 fmol of Pif1 to the reaction resulted in a
stimulation of FEN1 cleavage by 16.6-fold on the 2-nt flap sub-
strate, 10.5-fold on the 6-nt flap substrate, and 9.4-fold on the
30-nt flap substrate. A similar experiment was also performed
in the absence of ATP to determine whether the helicase func-
tion of Pif1 is in any way responsible for its ability to stimulate
FEN1. We observed that, like Dna2, Pif1 is able to stimulate
FEN1 cleavage even in the absence of ATP. A Pif1 helicase-
deficient mutant was also utilized to further confirm that the
stimulation of FEN1 by Pif1 does not require its helicase func-
tion (data not shown).
We expected that Pif1 would exhibit weak binding to a 2- or
6-nt flap but would bind avidly to a 30-nt flap. To confirm, we
performed an EMSA utilizing all three substrates in the pres-
ence of Pif1 (Fig. 3B).Weobserved a very low level of binding on
the 2-nt flap, even at 500 fmol of protein. As expected, the
amount of binding increased on the 6-nt flap, although the
amount of Pif1 bound was still low. On the 30-nt flap, binding
was evident even at 50 fmol of Pif1 and even more efficient at
500 fmol of Pif1. This result is consistent with our expectation
that Pif1 would bind poorly to the short flap substrates, if at all,
but readily to the 30-nt flap substrate.
In order to determine how the helicase of Pif1 is functioning
on the different length flaps utilized in our previous assays, we
performed a helicase assay. In addition to characterizing the
helicase ability of Pif1, we also sought to confirm that Pif1 was
not disrupting our substrates by removing the downstream
primer. At 50 fmol of Pif1, the maximum amount used in our
cleavage assay, we saw minimal unwinding of the downstream
primer and only on the 30-nt flap (Fig. 2). This level of Pif1 was
chosen intentionally with the expectation that it would not dis-
rupt the substrate. At the higher concentration of 500 fmol,
however, Pif1 displayed helicase activity, most effective on the
30-nt flap substrate, with someunwinding on the 6-nt flap. This
confirms what we expected; there is no helicase activity of Pif1
directly on the 2-nt flap and minimal activity on the 6-nt flap,
and Pif1 is able to freely interact with the 30-nt flap. This pat-
tern of unwinding is consistent with our hypothesis that Pif1,
on short flaps, is at first working to stimulate FEN1 cleavage.
However, after a critical flap length is reached, Pif1 is able to
bind to the flap, allowing its helicase function to act. This allows
Pif1 to lengthen the flap, thereby biasing the processing of the
flap toward the two-nuclease pathway.
Effect of RPA on FEN1 Cleavage—RPA is a key component of
the Okazaki fragment maturation pathway, responsible for
switching processing from the one-nuclease pathway to the
two-nuclease pathway via binding of the flaps. To better under-
stand these actions of RPA, wemeasured regulation of FEN1 by
RPA on the same substrates that revealed stimulation of FEN1
by Dna2 and Pif1.
Amounts of RPA ranging from 0 to 100 fmol were added to
reactions containing FEN1. This resulted in a dose-dependent
stimulation of FEN1 cleavage by RPA (Fig. 4A). On the 2- and
6-nt flap substrates, to which RPA cannot stably bind, FEN1
FIGURE 3. Pif1 stimulates FEN1 cleavage of 2-, 6-, and 30-nt flap sub-
strates. A, cleavage by FEN1 (2 fmol) was assayed on a 2-, 6-, and 30-nt flap
substrate in the presence or absence of ATP and varying amounts of Pif1 (5,
15, 25, or 50 fmol) as indicated in the figure and described under “Experimen-
tal Procedures.” Substrate depictions and designations are as in Fig. 1. B, Pif1
binding activity (50 or 500 fmol) was measured on a 2-, 6-, and 30-nt flap
substrate by non-denaturing PAGE.
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cleavage was increased by 9.3- and 8.3-fold, respectively, at 100
fmol of RPA. For the 30-nt flap substrate, we included two addi-
tional, higher amounts of RPA, 200 and 300 fmol. This allowed
us to measure the expected inhibition of FEN1 by RPA on long
flaps. At lower levels, RPA was indeed able to stimulate FEN1
cleavage; there was a 2-fold stimulation of FEN1 cleavage at 100
fmol of RPA. However, at 300 fmol of RPA, at which we
expected stable coating of the flap, FEN1 cleavagewas inhibited
to 25% of its basal level. As with our previous assays, this exper-
iment was also performed in the absence of ATP. We observed
a generally similar stimulation/inhibition pattern irrespective
of inclusion of ATP, although inhibition of FEN1 on the 30-nt
flap substrate occurred at lower concentrations in the absence
ofATP. This could simply be a result of a lower ionic strength of
our buffer without the ATP present.
To confirm expected binding characteristics of RPA, we per-
formed an EMSAutilizing all three substrates in the presence of
RPA (Fig. 4B). There was little binding of RPA on the 2- and
6-nt flaps at 50 fmol of protein, but there was substantial bind-
ing at 500 fmol. RPA is expected to exhibit a low affinity binding
mode on shorter flaps, but once bound, it may encourage local
melting until the flap is long enough formore stable interaction.
On the 30-nt flap, substantial binding was evident at 50 fmol of
RPA, with a complete substrate shift at 500 fmol.
Finally, we performed a melting assay for RPA. Although
RPA does not have helicase activity, high levels of RPA have
been show to melt double-stranded DNA. Therefore, we
intended to confirm that RPA was not removing either our
upstream or downstream primers. At 50 fmol of RPA, we saw
no removal of either primer, and even at 500 fmol of RPA,
removal of either primer from the template was not observed
(Fig. 2).
RPA has previously been reported to stimulate FEN1 cleav-
age. In 2003, Chai et al. (28) observed that on a 9- or 1-nt flap
substrate, the presence of RPAwould stimulate FEN1 cleavage.
Biswas et al. (29) also noticed a similar stimulation followed by
inhibition of FEN1 as RPA is titrated onto a 16-nt flap substrate.
The detailed mechanism of RPA stimulation of FEN1 and
whether it involved RPA interaction with the substrate was not
explored. Based on our results, stimulation of FEN1 by RPA
does not appear to derive from an interaction of RPA with the
flap substrate but rather a direct interaction with FEN1.
After observing stimulation of FEN1 cleavage by Dna2, Pif1,
and RPA, we also performed several negative controls. We
showed that boiled Dna2, Pif1, and RPA do not possess the
ability to stimulate FEN1 cleavage (data not shown). Addition-
ally, we noted that stimulation of FEN1 cleavage was species-
specific because human Dna2 and RPA failed to stimulate
S. cerevisiae FEN1 (data not shown).
Additionally, to confirm that the stimulation of FEN1 by our
proteins did not result from a contaminant in our protein prep-
arations, Dna2, Pif1, and RPA (each containing a His6 tag) were
allowed to adsorb to an Ni2-NTA-agarose column. Following
protein sequestration, the flow-through supernatant fraction
was added to FEN1 and produced no stimulation of cleavage.
Following elution of each protein from the nickel-agarose col-
umn, it stimulated FEN1 cleavage (data not shown).
FIGURE 4. RPA stimulates FEN1 cleavage of 2-, 6-, and 30-nt flap sub-
strates. A, cleavage by FEN1 (2 fmol) was assayed on a 2-, 6-, and 30-nt flap
substrate in the presence or absence of ATP and varying amounts of RPA (15,
25, 50, or 100 fmol,with twoadditional reactions containing200and300 fmol
on the 30 nt flap substrate) as indicated in the figure and described under
“Experimental Procedures.” Substrate depictions and designations are as in
Fig. 1. B, RPA binding activity (50 or 500 fmol) was measured on a 2-, 6-, and
30-nt flap substrate by non-denaturing PAGE.
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Effect ofDna2, Pif1, or RPAonFEN1Cleavage of anRNAFlap—
Flaps are created when pol  displaces the primer laid down by
pol  and then extended by pol , which would generate an
RNA segment of 10–12 nt on the 5-end, followed by DNA.
However, neither Dna2, Pif1, nor RPA is known to bind to sin-
gle-stranded RNA. Therefore, it was important to determine
whether protein components of the two-nuclease pathway are
capable of stimulating FEN1 on a flap with a 5 RNA segment.
For these experiments, we utilized a substrate containing a
6-nt-long 5-flap composed entirely of RNA. At the base of the
flap, there are 6 additional nucleotides of RNA annealed to the
DNA template. This represents the 12 nt of RNA anticipated to
be laid down by pol . We then repeated the titrations of Pif1,
Dna2, and RPA that we performed previously, utilizing the
DNA flap substrates.
In each case, we observed stimulation of FEN1 cleavage.
There was an approximately 12-fold stimulation at 50 fmol of
Dna2 (Fig. 5A) and an approximately 13-fold stimulation at 50
fmol of Pif1 (Fig. 5B).Moreover, at 50 fmol of RPA, FEN1 cleav-
age was stimulated 8-fold (Fig. 5C). These values are consistent
with the level of stimulation observed with a DNA flap sub-
strate. We noted that with the RNA substrate, FEN1 cleavage
produced two bands. This is not surprising because FEN1
sometimes will move 1 nt further into the downstream primer,
where it then can cleave a second time. Therefore, for analysis
of these results, FEN1 cleavagewas assessed as a combination of
the two cleavage products.
Effect of the Combination of Dna2, Pif1, and RPA on FEN1
Cleavage—After observing the ability of Dna2, Pif1, and RPA to
stimulate FEN1 individually, we further explored the combined
effect of all three proteins on FEN1 activity. One could imagine
a situation in which each protein stimulates FEN1 in a different
way, perhaps by inducing different conformational changes
within FEN1. In that case, we would expect that adding differ-
ent proteins would produce an additive stimulation of FEN1.
Alternatively, if each protein component induced the same
structural change in FEN1, then we would expect that there
would be a maximal level of stimulation that one protein could
impose, which could not be exceeded by the addition of one or
more additional stimulatory proteins.
First, we determined the amounts of either Dna2, RPA, or
Pif1 necessary tomaximally stimulate a very low level (0.2 fmol)
of FEN1 on a 6-nt flap. The low level ensured that additive
stimulations could be readily detected. Themaximum stimula-
tory amounts were determined to be 400 fmol of Dna2, 400
fmol of RPA, and 300 fmol of Pif1 (data not shown). Using these
concentrations, we then added Dna2, RPA, and Pif1 to FEN1 in
different combinations (Fig. 6). FEN1 controls of 10 and 2 fmol
were also included. The 10 fmol of FEN1 was used to demon-
strate that FEN1 can cleave 100% of our substrate. 2 fmol (a
10-fold increase over the 0.2 fmol control) was used to more
easily visualize a basal level of FEN1 cleavage.We observed that
the highest stimulation of FEN1 cleavage by a single protein
resulted from the addition of Dna2 (42.9% cleavage). When
adding all three proteins together, there was little difference in
the amount of FEN1 cleavage compared with only adding Dna2
(46.8%). Combining two proteins had little effect on the maxi-
mal cleavage observed as well. Rather, although each protein
stimulated to a somewhat different maximum, the various
combinations of proteins stimulated to a maximum that was
not substantially different from the stimulation level with Dna2
alone. These results demonstrate that the two-nuclease path-
way proteins do not exhibit an additive stimulatory effect and
that the proteins are each not stimulating FEN1 in a unique
manner.
Protein Components of the Two-nuclease Pathway Are Pres-
ent in a Complex with FEN1—Stimulation of FEN1 by each
protein component of the two-nuclease pathway even when
those proteins were not expected to interact with the substrate
FIGURE5.Two-nucleasepathwayproteins stimulate FEN1onanRNA flap
substrate. A, cleavage by FEN1 (2 fmol) was assayed on a 6-nt RNA flap sub-
strate in the presence of varying amounts of Dna2 (5, 15, 25, or 50 fmol) as
indicated in the figure and described under “Experimental Procedures.” The
substrate is depicted at the top with the location of the radiolabel indicated
by an asterisk. The dotted line represents the RNA region of the substrate. The
presence () and absence () of components are indicated. B, cleavage by
FEN1 (2 fmol) on a 6-nt RNA flap substrate in thepresence of varying amounts
of Pif1 (5, 15, 25, or 50 fmol). C, cleavage by FEN1 (2 fmol) on a 6-nt RNA flap
substrate in the presence of varying amounts of RPA (5, 15, 25, or 50 fmol).
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suggested direct interactions of Dna2, Pif1, and RPA with
FEN1. Pif1 andDna2 are known to genetically interact (19), and
direct associations between human FEN1 and humanDna2 and
S. cerevisiae Dna2 and S. cerevisiae RPA70 have also been
shown (30, 31). Binding assays were performed to clarify the
direct interactions of S. cerevisiae FEN1with S. cerevisiaeDna2,
S. cerevisiae Pif1, and S. cerevisiaeRPA in vitro. Purified recom-
binant yeast proteins were bound to FEN1 overnight and were
immunoprecipitated the following daywith antibodies toDna2,
Pif1, or RPA70. The immunoprecipitates were separated on a
SDS-polyacrylamide gel, and Western blotting was performed
using antibody against FEN1. The nonspecific IgG control
showed no contamination with FEN1 (Fig. 7, lane 1). Lane 2
served as a positive control for FEN1. Direct interaction of
Dna2 and FEN1 was detected and confirmed as previously
reported (Fig. 7, lane 5). Pif1 (Fig. 7, lane 8) andRPA (Fig. 7, lane
11) also associated with FEN1 in vitro. Lanes 4, 7, and 10 serve
as controls to demonstrate that Dna2, Pif1, and RPA, respec-
tively, are not contaminatedwith FEN1 and thus stimulation by
these proteins is not a result of additional FEN1 being included
with these proteins. Lanes 3, 6, and 9 are controls to show that
the Dna2, Pif1, and RPA antibodies, respectively, do not bind
FEN1.
Our results suggest that each protein component of the two-
nuclease pathway is able to directly interact with and stimulate
FEN1 in vitro. When all of the protein components of the two-
nuclease pathway were simultaneously allowed to bind FEN1
and then individually immunoprecipitatedwith antibodies spe-
cific for either Dna2, Pif1, or RPA and finally immunoblotted
for FEN1, we still observed interaction between individual pro-
teins and FEN1 (Fig. 8). However, the quantity of each protein
bound to FEN1 was lower in the presence of the other proteins.
Possibly, the presence of other proteins in a complex partially
occluded the antibody interaction sites, decreasing the effi-
ciency of immunoprecipitation. Alternatively, this could be an
indication of partial or even complete overlap of protein bind-
ing sites, such that the proteins competed for binding FEN1.
Additionally, interactions of the proteins among themselves
might have altered the efficiency of their binding to FEN1. Our
experiments are not able to distinguish among these possibili-
ties. Results are consistent with formation of a complex con-
taining all of the proteins but also with complexes that allow
just one or two proteins at a time to bind FEN1.
DISCUSSION
Current models of eukaryotic Okazaki fragment processing
envision that it occurs by two enzymatic pathways. The one-
nuclease pathway is proposed to convert the large majority of
short flaps to nicks for ligation through the nuclease action of
FEN1. The two-nuclease pathway is thought to process those
flaps that escape FEN1 cleavage to become long. The actions of
these pathways until now have been viewed as sequential and
functionally independent. They alsomay be viewed as unidirec-
tionally competitive, in the sense that the one-nuclease path-
way reduces substrate available for two-nuclease processing.
We demonstrate here that all of the unique protein compo-
nents proposed to participate in the two-nuclease pathway,
Dna2, Pif1, and RPA, stimulate the cleavage activity of FEN1 via
FIGURE 6. Individual proteins are able maximize stimulation of cleavage
by FEN1. Cleavage by FEN1 (0.2 fmol) was assayed on a 6-nt flap substrate in
the presence of combinations of Dna2 (400 fmol), RPA (400 fmol), and Pif1
(300 fmol) as indicated in the figure and described under “Experimental Pro-
cedures.” Control reactions assessing cleavage at 2 and 10 fmol FEN1 are
shown. Substrate depictions and designations are as in Fig. 1.
FIGURE 7. Dna2, Pif1, and RPA each directly bind FEN1. Lane 1, a nonspe-
cific IgG control. Lane 2, a positive control for 200 pg of purified FEN1. Lanes 3
(containing 1 ng of purified FEN1), 4 (containing 1 ng of purified Dna2), and 5
(containing 1 ng of purified FEN1 and 1 ng of purified Dna2) were immuno-
precipitated (IP) with antibody to Dna2. Lanes 6 (containing 1 ng of purified
FEN1), 7 (containing 1 ng of purified Pif1), and 8 (containing 1 ng of purified
FEN1 and 1 ng of purified Pif1) were immunoprecipitated with antibody to
Pif1. Lanes 9 (containing 1 ngof purified FEN1), 10 (containing 1 ngof purified
RPA) and 11 (containing 1 ng of purified FEN1 and 1 ng of purified RPA) were
immunoprecipitated with antibody to RPA. The immunoprecipitates were
separated on an SDS-polyacrylamide gel, and Western blotting (IB) was per-
formed using antibody against FEN1.
FIGURE 8. Binding of Dna2, Pif1, RPA, and FEN1. Lane 1, a nonspecific IgG
control; lane 2, a positive control for 200 pgof purified FEN1. Lanes 3 (contain-
ing 1 ng of purified FEN1 and 1 ng of purifiedDna2), and 4 (containing 2 ng of
purified Pif1, 2 ng of purified RPA, 1 ng of purified FEN1, and 1 ng of purified
Dna2)were immunoprecipitated (IP) with antibody toDna2. Lanes 5 (contain-
ing 1 ng of purified FEN1 and 1 ng of purified Pif1), and 6 (containing 2 ng of
purified Dna2, 2 ng of purified RPA, 1 ng of purified FEN1, and 1 ng of purified
Pif1) were immunoprecipitated with antibody to Pif1. Lanes 7 (containing 1
ng of purified FEN1 and 1 ng of purified RPA) and 8 (containing 2 ng of puri-
fied Dna2, 2 ng of purified Pif1, with 1 ng of purified FEN1 and 1 ng of purified
RPA) were immunoprecipitated with antibody to RPA. The immunoprecipi-
tates were separated on a SDS-polyacrylamide gel, and Western blotting (IB)
was performed using antibody against FEN1.
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direct interaction. This stimulation is ATP-independent and
occurs on substrates with flaps that are too short to bind these
two-nuclease pathway proteins. Additionally, although Pif1
and RPA cannot bind to RNA, andDna2 cannot cleave RNA, all
three proteins are able to stimulate FEN1 on a flap substrate
containing a 5 RNA region.
Relative use of the two pathways has been inferred from
reconstitution of Okazaki fragment processing using oligonu-
cleotide substrates and purified enzymes in vitro (12, 20). In the
reconstituted system, instead of using a preformed flap sub-
strate, pol  actively creates a flap. Pol , complexed with
PCNA, extends an upstream primer into a downstream primer,
generating a flap by strand displacement synthesis, the mecha-
nism of flap creation in Okazaki fragment processing. In the
presence of FEN1, the large majority of cleavage products were
less than 8 nt long (12). These observations suggest that the nat-
ural one-nuclease pathway is highly efficient and that the two-
nuclease pathway has evolved to catch a small percentage of the
flaps that are missed by effective FEN1 cleavage. Although it is
currently not very clearwhy certain flaps escape FEN1 cleavage,
one can imagine the deleterious effects on genome stability if
the systemwere not equipped with a fail-safemechanism in the
form of the two-nuclease pathway. FEN1 haploinsufficiency
has been linked to genomic instability and rapid progression to
cancer (32, 33). Furthermore, post-translational modification
of FEN1 by either phosphorylation or acetylation inhibits its
cleavage function (34–36). Uncoupling of FEN1 from the repli-
some or post-translational modification of the protein might
drive the system to utilize the two-nuclease pathway.
Assuming that the replication machinery has evolved to
maximize genome stability, it makes sense to favor processing
of flaps by FEN1 while they are short because problems caused
by longer flap intermediates are easily envisioned. Long flaps
can fold back onto themselves, forming secondary structures
anticipated to inhibit processing. Formation of secondary
structures not only inhibits the one-nuclease pathway, but
these structures are also refractory to action by protein compo-
nents of the two-nuclease pathway thereby creating an unde-
sirable, unresolved structure. The long flaps can also promote
harmful recombination events that would disrupt the continu-
ity of the DNA sequence. Additionally, it has been shown that
repeated cleavage of short flaps by FEN1 promotes more effec-
tive strand displacement synthesis by pol  (6, 11). Thus, quick,
efficient cleavage of short flaps would help lagging strand pro-
cessing to the continuous final product occur more quickly,
avoiding a series of long-lived breaks in the chromosome that
can also promote recombination.
Furthermore, the requirement for removal of the RNA por-
tion of the mixed primer made by pol  highlights the need for
efficiency of the one-nuclease pathway. Pif1 cannot bind to a
single-stranded RNA flap (24), and RPA shows approximately
1000-fold lower binding affinity to single-stranded RNA as
compared with single-stranded DNA (37, 38). Moreover,
although Dna2 is able to track over an RNA flap, it cannot
cleave (15, 21). FEN1, however, is similarly active on RNA or
DNA flaps (39). Therefore the RNA portion of the flap must be
either fully displaced or displaced and cleaved before the two-
nuclease pathway is even an option. Again, this suggests that
the replication system has evolved in a way that favors FEN1
cleavage by allowing what would otherwise be inactive mem-
bers of the two-nuclease pathway to stimulate FEN1 cleavage
even when they themselves cannot bind or cleave.
With further displacement, the region of DNA beyond the
RNA begins to become single-stranded. FEN1 cleavage can
now generate a nick that serves as a substrate for the ligation
that completes fragment processing. Our results indicate that
while the DNA flap is short, neither Pif1 nor Dna2 can exhibit
helicase activity, but they can exert a stimulatory effect on
FEN1. Only after additional DNA flap displacement, and only
in the infrequent cases inwhich the flaps escape FEN1 cleavage,
would the flaps achieve lengths of 20 nt. At this point, RPA
would bind to inhibit FEN1, Pif1 would accelerate displace-
ment, and these flaps would require a shift to the two-nuclease
pathway.
To further characterize the manner in which Pif1, Dna2, and
RPA stimulate FEN1, we evaluated whether these proteins
could each stimulate FEN1 in an additive manner or whether
the presence of any one of the three proteins was capable of
driving FEN1 to maximum activity. When using low levels of
FEN1 and observing stimulation by each individual protein, we
note that the addition of a secondor third protein has little to no
effect on the ability of FEN1 to cleave over the stimulation
already conferred. The highest level of stimulation from an
individual protein is fromDna2, causing an increase in cleavage
from 0.6% to43%, a stimulation of71-fold. The addition of
RPA and Pif1 to the reaction only had a modest effect, increas-
ing cleavage to about 47%.
We also demonstrated that each of the unique proteins of the
two-nuclease pathway has a direct binding affinity for FEN1,
independent of the presence of a DNA substrate. However, our
binding measurements could not establish unambiguously
whether all three proteins can bind FEN1 simultaneously or
whether they have evolved for a process of sequential binding
during the execution of the two-nuclease pathway. Because sin-
gle interactions or complexes involving combinations of two or
all three proteins are all capable of maximum stimulation of
FEN1, the effect on FEN1 cleavage of short flaps should be
similar whether the proteins are bound simultaneously or
sequentially.
Previous work has demonstrated that another protein
involved in Okazaki fragment processing, PCNA, is also able to
influence FEN1 cleavage. PCNA is a central component ofOka-
zaki fragment processing that interacts with pol , FEN1, and
DNA ligase I. It is a processivity factor for the polymerase and a
stimulator of FEN1 and the ligase. It is also thought to coordi-
nate the sequential actions of these proteins. PCNA and its
similarly structured DNA repair counterpart, the 9-1-1 check-
point complex, both bind and stimulate FEN1. Stimulation by
PCNA has been extensively investigated (40–42). To exert
stimulation, PCNA must be loaded onto the double-stranded
part of the FEN1 substrate, specifically upstream of the flap.
Evidence suggests that it captures the FEN1 as it slides to the
base of the flap and stabilizes FEN1 interactionwith its cleavage
site. Although PCNAmay also induce a conformational change
in FEN1 that increases activity, effects on tethering FEN1 to its
cleavage site and induction of a more active conformation are
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not readily distinguished. PCNA and 9-1-1 are capable of stim-
ulating FEN1 cleavage activity over 10-fold, similar to the stim-
ulation factors conferred by the protein components of the
two-nuclease pathway.
FEN1, like other enzymes, presumably has a stimulation
maximum that cannot be exceeded.Whereas experiments ana-
lyzing FEN1 cleavage function on cognate substrates in vitro are
done in the presence of either individual or a combination of
stimulating proteins, in the cellular system, the modes of inter-
action and stimulation might vary. For example, FEN1 interac-
tion with PCNA might primarily provide for an increase in
binding to the flap, and interactions with Dna2, Pif1, and RPA
may change the conformation of FEN1 in a suchmanner that it
can optimally function on the substrate.
Based on these observations and binding studies, we know
that FEN1 is capable of complexing with multiple proteins,
including Dna2, Pif1, RPA, and PCNA. Moreover, it appears
that only PCNA tethers the FEN1 to its cleavage site on a short
flap substrate because the two-nuclease proteins do not bind
short flaps. However, the two-nuclease proteins are capable of
interacting with FEN1 and each other, in a way that is likely to
raise their local concentrations near flaps.When the flaps grow
long, the two-nuclease components candevelop additional pro-
ductive interactions with the substrate. These interactions
would help the two-nuclease components to be in proximity to
their long flap substrates as soon as they are created.
In summary, the protein components of the two-nuclease
pathway for eukaryotic Okazaki fragment processing appear to
interact directly with FEN1 in order to stimulate FEN1 cleavage
of short flaps. We propose that these proteins form a complex
with FEN1 and PCNA that involves either simultaneous or suc-
cessive interactions.Moreover, if a flap becomes long enough to
require the two-nuclease pathway, the presence of the complex
ensures that the two-nuclease proteins are available to carry out
their functions.
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